Log In
Print
BCIQ
Print
Print this Print this
 

Agrylin, Xagrid, anagrelide

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionSmall molecule that reduces platelet count
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationThrombocytopenia
Indication DetailsTreat essential thrombocytopenia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today